Cargando…
A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer
Precision medicine has emerged as an important paradigm in oncology, driven by the significant heterogeneity of individual patients’ tumour. A key prerequisite for effective implementation of precision oncology is the development of companion biomarkers that can predict response to anti-cancer thera...
Autores principales: | Shin, Sung-Young, Centenera, Margaret M., Hodgson, Joshua T., Nguyen, Elizabeth V., Butler, Lisa M., Daly, Roger J., Nguyen, Lan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892654/ https://www.ncbi.nlm.nih.gov/pubmed/36743211 http://dx.doi.org/10.3389/fmolb.2023.1094321 |
Ejemplares similares
-
Development of machine learning models for the screening of potential HSP90 inhibitors
por: Khan, Mohd Imran, et al.
Publicado: (2022) -
Bacterial Hsp90 Facilitates the Degradation of Aggregation-Prone Hsp70–Hsp40 Substrates
por: Fauvet, Bruno, et al.
Publicado: (2021) -
Differences in conformational dynamics within the Hsp90 chaperone family reveal mechanistic insights
por: Graf, Christian, et al.
Publicado: (2014) -
The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
por: Dekker, Françoise A., et al.
Publicado: (2021) -
Targeting extracellular Hsp90: A unique frontier against cancer
por: Sager, Rebecca A., et al.
Publicado: (2022)